These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9389727)

  • 61. X-linked hypophosphatemic rickets--a report of 2 cases and review of literature.
    Yong SM; Aik S
    Med J Malaysia; 2000 Sep; 55 Suppl C():101-4. PubMed ID: 11200035
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Vitamin D-resistant rickets and hemophilia A--lack of close linkage on the X chromosome.
    Welt SI; Graham JB; Kossove DB; Kirkman HN
    Am J Hum Genet; 1973 Jan; 25(1):105-7. PubMed ID: 4346240
    [No Abstract]   [Full Text] [Related]  

  • 63. Hypophosphatemic rickets: easy to diagnose, difficult to treat.
    Garg RK; Tandon N
    Indian J Pediatr; 1999; 66(6):849-57. PubMed ID: 10798150
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Mapping of the gene for cleidocranial dysplasia in the historical Cape Town (Arnold) kindred and evidence for locus homogeneity.
    Ramesar RS; Greenberg J; Martin R; Goliath R; Bardien S; Mundlos S; Beighton P
    J Med Genet; 1996 Jun; 33(6):511-4. PubMed ID: 8782054
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Dombrock blood group (DO): assignment to chromosome 12p.
    Eiberg H; Mohr J
    Hum Genet; 1996 Nov; 98(5):518-21. PubMed ID: 8882867
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Hypophosphatemic rickets.
    Carey DE
    J Pediatr; 1996 Jul; 129(1):177-8. PubMed ID: 8757586
    [No Abstract]   [Full Text] [Related]  

  • 67. Tumor-induced osteomalacia.
    Farrow EG; White KE
    Expert Rev Endocrinol Metab; 2009 Sep; 4(5):435-442. PubMed ID: 20228870
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Electron optic analysis of human dentin in hypophosphatemic vitamin D-resistant rickets (report of a kindred with consanguinity).
    Sauk JJ; Witkop CJ
    J Oral Pathol; 1973; 2(4):203-14. PubMed ID: 4363334
    [No Abstract]   [Full Text] [Related]  

  • 69. CLC-5 chloride channels and renal disease.
    Kumar R
    Kidney Int; 1998 Jan; 53(1):228-9. PubMed ID: 9453024
    [No Abstract]   [Full Text] [Related]  

  • 70. Autosomal recessive hypophosphataemia.
    Baker LR; Stamp TC
    Arch Dis Child; 1989 Aug; 64(8):1209. PubMed ID: 2782942
    [No Abstract]   [Full Text] [Related]  

  • 71. Coamplification in human breast-tumors and physical linkage at chromosomal band 12p13, of ccnd2 and fgf6 genes.
    Dib A; Adelaide J; Courjal F; Courseaux A; Jacquemier J; Gaudray P; Theillet C; Pebusque M; Birnbaum D
    Int J Oncol; 1994 Dec; 5(6):1375-8. PubMed ID: 21559724
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Fibroblast Growth Factor 23 Bone Regulation and Downstream Hormonal Activity.
    Clinkenbeard E
    Calcif Tissue Int; 2023 Jul; 113(1):4-20. PubMed ID: 37306735
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Molecular Diagnoses of X-Linked and Other Genetic Hypophosphatemias: Results From a Sponsored Genetic Testing Program.
    Rush ET; Johnson B; Aradhya S; Beltran D; Bristow SL; Eisenbeis S; Guerra NE; Krolczyk S; Miller N; Morales A; Ramesan P; Sarafrazi S; Truty R; Dahir K
    J Bone Miner Res; 2022 Feb; 37(2):202-214. PubMed ID: 34633109
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Usefulness of
    Lee DY; Lee SH; Kim BJ; Kim W; Yoon PW; Lee SJ; Oh SJ; Koh JM; Ryu JS
    Sci Rep; 2021 Jan; 11(1):1819. PubMed ID: 33469091
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Validation of a next-generation sequencing (NGS) panel to improve the diagnosis of X-linked hypophosphataemia (XLH) and other genetic disorders of renal phosphate wasting.
    Thiele S; Werner R; Stubbe A; Hiort O; Hoeppner W
    Eur J Endocrinol; 2020 Nov; 183(5):497-504. PubMed ID: 33107440
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The Causes of Hypo- and Hyperphosphatemia in Humans.
    Koumakis E; Cormier C; Roux C; Briot K
    Calcif Tissue Int; 2021 Jan; 108(1):41-73. PubMed ID: 32285168
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Regulation of Fibroblast Growth Factor 23 by Iron, EPO, and HIF.
    Wheeler JA; Clinkenbeard EL
    Curr Mol Biol Rep; 2019 Mar; 5(1):8-17. PubMed ID: 31218207
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Genetic Variants Associated with Circulating Fibroblast Growth Factor 23.
    Robinson-Cohen C; Bartz TM; Lai D; Ikizler TA; Peacock M; Imel EA; Michos ED; Foroud TM; Akesson K; Taylor KD; Malmgren L; Matsushita K; Nethander M; Eriksson J; Ohlsson C; Mellström D; Wolf M; Ljunggren O; McGuigan F; Rotter JI; Karlsson M; Econs MJ; Ix JH; Lutsey PL; Psaty BM; de Boer IH; Kestenbaum BR
    J Am Soc Nephrol; 2018 Oct; 29(10):2583-2592. PubMed ID: 30217807
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The metabolic bone disease associated with the
    Hum JM; Clinkenbeard EL; Ip C; Cass TA; Allen M; White KE
    Bone Rep; 2017 Jun; 6():38-43. PubMed ID: 28377980
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Heritable and acquired disorders of phosphate metabolism: Etiologies involving FGF23 and current therapeutics.
    Clinkenbeard EL; White KE
    Bone; 2017 Sep; 102():31-39. PubMed ID: 28159712
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.